Navigation Links
DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
Date:3/3/2008

ANN ARBOR, Mich., March 3 /PRNewswire/ -- Terumo Heart, Inc. announced today that they have received conditional approval from the Food and Drug Administration (FDA) to begin enrollment in the US Pivotal Trial of the DuraHeart (TM) LVAS for a Bridge-to-Transplant (BTT) indication.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO )

(Photo: http://www.newscom.com/cgi-bin/prnh/20080303/CLM012 )

Dr. David Munjal, Vice President of Clinical Studies, Regulatory Affairs and Quality Systems at Terumo Heart, Inc., commented: "We are extremely pleased that FDA has allowed us to move directly to the Pivotal Trial based on our existing European data. The conditional approval was granted pending answers to some additional questions. Terumo Heart, Inc. has already responded to the FDA concerning these questions and final approval is anticipated in the near future."

Dr. Chisato Nojiri, M.D., Ph.D., Chief Executive Officer for Terumo Heart, Inc., said: "The approval of the IDE Pivotal Trial is a major milestone for Terumo Heart and we are especially pleased that the FDA has also issued approval for patients to be discharged home. This positive decision by the FDA was based on our robust preclinical data and the successful European clinical trial of the DuraHeart System."

The Pivotal Trial will be a multi-center, prospective, non-randomized study of 140 patients and will include up to 40 centers. The Principal Investigators will be Francis Pagani, M.D., Ph.D., from the University of Michigan and Yoshifumi Naka, M.D., Ph.D., from Columbia Presbyterian Hospital in New York.

The DuraHeart LVAS is a third generation circulatory support device intended to provide cardiac support for patients who are at risk of death due to end-stage left ventricular failure. It i
'/>"/>

SOURCE Terumo Heart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
2. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
3. Vermillion Receives Award From the Society of Gynecologic Oncologists
4. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
5. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
6. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
11. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... 17, 2014   DaVita HealthCare Partners Inc. ... the nation,s largest and most innovative health care ... – the company,s award-winning, leadership development and cultural ... teammates from around the globe were in attendance ... Academy is a two-day one-of-a-kind experience for new ...
(Date:10/16/2014)... (Nasdaq: CPHD ) today reported revenues for ... growth of 15% from $100.1 million for the third ... of 2014 was $(7.2) million, or $(0.10) per share, ... $(0.02) per share, in the third quarter of 2013.  ... debt discount and transaction costs, and amortization of purchased ...
(Date:10/16/2014)... -- Eight finalists, all representing outstanding innovation in pediatric ... for a chance to compete for one of two ... Second Annual Pediatric Surgical Innovation Symposium hosted by ... 24, 2014. Selected from a competitive field ... internationally, the finalists are: , Creative ...
Breaking Medicine Technology:DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3Cepheid Reports 2014 Third Quarter Results 2Cepheid Reports 2014 Third Quarter Results 3Cepheid Reports 2014 Third Quarter Results 4Cepheid Reports 2014 Third Quarter Results 5Cepheid Reports 2014 Third Quarter Results 6Cepheid Reports 2014 Third Quarter Results 7Cepheid Reports 2014 Third Quarter Results 8Cepheid Reports 2014 Third Quarter Results 9Cepheid Reports 2014 Third Quarter Results 10Cepheid Reports 2014 Third Quarter Results 11Cepheid Reports 2014 Third Quarter Results 12Cepheid Reports 2014 Third Quarter Results 13Cepheid Reports 2014 Third Quarter Results 14Cepheid Reports 2014 Third Quarter Results 15Cepheid Reports 2014 Third Quarter Results 16Cepheid Reports 2014 Third Quarter Results 17Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4
... TAMPA, Fla., April 16, 2007 /PRNewswire/ -- ... that it has received orphan drug designation ... its anti-viral therapy,ganciclovir, for the treatment of ... by Laboratoires Thea in Europe under,the brand ...
... - Data Presented at 2007 APA Meeting ... -- Data,from four new studies examining safety ... (SNRI) being studied as a potential treatment ... presented today at the,2007 American Psychiatric Association ...
Cached Medicine Technology:Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8
(Date:10/18/2014)... 2014 Stafford Communications , a ... the breast cancer awareness program called “Sleep Pink” on ... pink pajama parties where women and men can promote ... support of the program, Stafford’s employees wore pink pajamas ... Facebook Page. In exchange, Stafford Communications and the makers ...
(Date:10/18/2014)... 2014 Asbestos Likely More Widespread Than ... more widespread than previously thought, with newly discovered sources ... asbestos-rich areas are in locations not previously considered to ... be presented at the Annual Meeting of the Geological ... 20 October. , “These minerals were found where one ...
(Date:10/18/2014)... Australia (PRWEB) October 19, 2014 ... in Australia provide professional carpet cleaning services, ... Carpets are typically professionally cleaned every one to ... Flores, “Demand for industry services plummeted during the ... delayed discretionary services, including professional carpet cleaning.” The ...
(Date:10/18/2014)... Globally, the demand for antioxidants ... in the years to come. The projected growth ... of antioxidants remained surprisingly strong during the period ... all business sectors across the globe. Geographically, the ... followed by North America and China. Among the ...
(Date:10/18/2014)... One major trend upcoming in this market is ... making efforts to encourage people to donate organs. The ... process more transparent and easy. , Analysts forecast the ... at a CAGR of 16.85 percent over the period ... drivers in the market is an increase in the ...
Breaking Medicine News(10 mins):Health News:Stafford Communications Holds Second Annual Celebration to Raise Money for Breast Cancer 2Health News:Stafford Communications Holds Second Annual Celebration to Raise Money for Breast Cancer 3Health News:Asbestos Likely More Widespread Than Previously Thought 2Health News:Asbestos Likely More Widespread Than Previously Thought 3Health News:Carpet Cleaning Services in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Carpet Cleaning Services in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Global Antioxidants Industry Opportunities & 2018 Trends Now Available at MarketReportsOnline.com 2Health News:Global Antioxidants Industry Opportunities & 2018 Trends Now Available at MarketReportsOnline.com 3Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 2Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 3Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 4
... Call for Tough Physical/Mental Stimulus PlanORLANDO, Fla., March ... and fitness programs during the American Alliance for ... in Tampa, March 31-April 4 2009GeoFitness has developed ... the rapper Rikshaw to launch the nationwide "Get ...
... Complies with Updated Interoperability RequirementsWATKINSVILLE, Ga., March ... Information Technology (CCHIT(R)) today announced that Silk ... a CCHIT Certified(R) 08 Ambulatory EHR, and ... (EHR) criteria for office-based use. Ambulatory EHRs ...
... by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., posts ... Web 2.0 policy development providing insight into FDA,s point of view about ... pharmaceutical industry. , ... Washington, DC (PRWEB) March 17, 2009 -- Today ...
... by the Stanley Medical Research Institute and Johns Hopkins ... neurotic behavior in infected men and women. Between 25 ... 30 percent of the U.S. population - may be infected.Toxoplasma ... passed to humans when changing cat litter, gardening and petting. ...
... Cooperative, one of the largest non-profit cooperative group purchasing and ... strategic sourcing services, announce their integrated partnership today. This partnership ... , ... Erie, PA (PRWEB) March 17, ...
... The medical costs that businesses pay to care for ... for nearly a dozen healthy, full-term infants, according to new ... medical cost for healthy full-term babies from birth through their ... than $3,800 is paid for by health plans, according to ...
Cached Medicine News:Health News:GeoFitness Launches 'Get Moving America' Campaign to Improve Youth Health 2Health News:Silk Information Systems's Silk V 4.2 Receives 08 CCHIT Certification 2Health News:Silk Information Systems's Silk V 4.2 Receives 08 CCHIT Certification 3Health News:FDA's DDMAC Provides Insight on Pharmaceutical Companies and Web 2.0 in Eye on FDA Podcast 2Health News:Research Finds Popular Household Pets Transmit Dangerous Parasites to Humans 2Health News:MAGNET Cooperative and Procurex, Inc. Announce Integration Partnership Streamlining the Healthcare Industry's Purchasing Process 2Health News:MAGNET Cooperative and Procurex, Inc. Announce Integration Partnership Streamlining the Healthcare Industry's Purchasing Process 3Health News:Medical costs for one premature baby could cover a dozen healthy births 2Health News:Medical costs for one premature baby could cover a dozen healthy births 3
Pneumatic micro sagittal saw, 30k cpm, available with various hose connector styles....
... The SmartDriver System consists ... in Pneumatic, Electric and Battery ... of couplers that can be ... orthopedic surgical applications., ,Smartdriver ...
The 7700 Reciprocating Saw completes the large power system with our simple twist-lock blade hub and selection of saw blades....
... System consists of a pistol-grip handpiece available ... a wide range of couplers that can ... surgical applications., ,MicroAire SmartDriver. Modular Pistol-Grip ... with different module for drilling, pinning, cutting, ...
Medicine Products: